[ Price : $8.95]
FDA assigns a user fee goal date for Salix Pharmaceuticals sNDA for Xifaxan for treating irritable bowel syndrome with diarrhea.[ Price : $8.95]
FDA awards the Critical Path Institute a second five-year grant that could total $10.5 million.[ Price : $8.95]
Attorney Suzanne OShea says Congress needs to clarify its intent so FDA knows how to classify combination products for review eith...[ Price : $8.95]
CDRH associate director for international affairs Kimberly A. Trautman says an FDA-backed medical device single audit program shou...[ Price : $8.95]
President Obamas science and technology advisors release a report and strategy on combating antibiotic resistance.[ Price : $8.95]
FDA clears an Intuitive Surgical 510(k) for its da Vinci S and da VinciSi Surgical Systems and their use in benign, base-of-tongue...[ Price : $8.95]
FDA approves an Eli Lilly NDA for Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control in adu...[ Price : $8.95]
Consumer advocates say FDA should either find that a Ranbaxy ANDA for generic Nexium is ready for immediate approval and market en...